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Abstract
This project aimed to obtain a set of fluorescent nucleoside analogues
that closely resemble cytosine with extending the aromatic surface
(extended conjugation) for enhance the photophysical properties.

In

addition to synthesize new fluorescent nucleoside analogues and evaluate
their photophysical properties, this project aimed to understand the effects
of donor substituent on the tC photophysical properties.
The main goal of these studies is to develop highly fluorescent
nucleotide analogues. We first were looking to synthesize tCC fluorescent
nucleotide with the pyrimido[4,5-b]quinolone. In this part, 2-chloro-3formylquinoline was easily prepared, yet the cyclization of 2-chloro-3formylquinoline with urea or guanidine HCl was the most challenging that
faced us. However, we have synthesized 2-amino [4,5-b]quinoline-one ring
tCC under super dry reaction conditions in <10% yield.
The second goal was synthesizing new modified fluorescent nucleoside
derivatives of tricyclic cytidine, which structurally mimics natural cytidine,
and evaluates the photophysical properties of the new fluorescent tC
nucleoside to understand the affects of the donor substituent, OCH3, group
on tC. In this part, we have reported new tC nucleoside derivatives with
ii

electrons donor substituent OCH3 group at carbon 7, tC7OMe, and the other
at carbon 8, tC8OMe. These different substitution positions offer important
distinctions between the design of the tC, tC8OMe, and tC7OMe. The
unsubstituted tC nucleoside was easy to synthesize. In contrast, the
synthetic strategy of the tC7OMe nucleoside that has electron donor
substituent group OCH3 located at carbon 7 and para to amino group is
synthetically less challenging and higher yielding than synthesis of tC8OMe
which has OCH3 group substituent meta to amine group. Moreover, the
photophysical properties of the fluorescent nucleoside derivatives of tC
have been evaluated. Fluorescence studies of modified tC nucleosides
demonstrated

distinguish

fluorescence

emission

and

absorption

wavelengths for tC7OMe, and tC8OMe, which displayed higher quantum yields
and brightness compared to unmodified tC, dependent on mismatch
position of the electron donor group (7 or 8) on the tC.

This can be

explained by the fact that the donor group OCH3 which allow for extended
conjugation of unshared pairs of electrons lead to increases the freedom of
the

-electrons and likely to raise the fluorescence. Also, our fluorescence

study established that there are effects of the different positions of
substituent donor group. The fluorescence emission wavelength of tC8OMe,
where the OCH3 is meta to amino group, is red sifted longer than the
fluorescence emission wavelength of tC7OMe, where the OCH3 is para to
amino group; however, tC7OMe exhibited higher quantum yield and
brightness than tC8OMe.

iii
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Chapter 1
Introduction
1.1 Deoxyribonucleotides (DNA)

In 1953 the three-dimensional structure of the DNA double helix, which
is two polynucleotide chains twisted around each other bonded via
hydrogen bonds in the form of a double helix (Figure 1.1), was discovered
by Watson and Crick.1 Since that time, DNA, which is considered a key
component of life, became the focus of many researchers. DNA (genetic
material)

2

is a molecule that is responsible for storage, duplication, and

investigation of the genetic information in bodies of living organisms;
therefore, it plays a vital role in all living organisms.3

1

Figure 1.1: Double-helix Structure of the DNA Molecule

2

1.1.1 Major Structures of DNA:

In the double helix DNA the residues (nucleotides) are built up of four
bases: adenine (A) , thymine (T), cytosine (C) and guanine (G) that are
connected via specific binding between the nitrogenous nucleobases
knows as Watson-Crick hydrogen bonding, adenine (A) always pairs with
thymine (T) / (uracil (U) in case of RNA) and visa versa, while guanine (G)
always pairs with cytosine (C) and visa versa 3 (Figure 1.2).

3

1.1.2 Nucleosides and Nucleotides

Nucleotides are monomeric biomolecular units of nucleic acids (DNA
and RNA) that are created from nucleosides. Nucleotides consist of three
components covalently bonded together: 1 (Figure1.3)
I. Nitrogenous Bases (Heterocyclic bases)
The nitrogenous bases of DNA are divided into two classes
Purines(bicyclic)
1. Guanine.

2- amino-6-oxypurine (figure1.4 a)

2. Adenine

6-aminopurine (figure1.4 b)

Pyrimidines (monocyclic)
1. Cytosine 2-oxy-4-amino pyrimidine (figure1.4c)
2. Thymine 2,4-oxy 5-methyl pyrimidine (DNA) (figure1.4d)
3. Uracil

2,4-oxypyrimidine (RNA) (figure 1.4e)

II. A Pentose (5-carbon sugar) – ribose or 2′-deoxyribose..
These nitrogenous bases are connected to the five membered ring
sugar, a furanose, via a β-glycosidic bond (figure1.3).
III. A Phosphate Group
Nucleotides have one, two or three phosphate group(s), while the
nucleosides have a hydrogen atom instead of the phosphate group(s).1
4

Phosphate groups are bridge linkages that link nucleotides in a phosphodiester backbone between the 3' carbon of one deoxyribose molecule and
the 5' carbon of another.

Purine or
Pyrimidine
base

Purine or
Pyrimidine
base
Phosphate
H O
O

O
O P O
O-

-

Pentose

OH

O
Pentose
OH

Nucleoside

Nucleotide

Figure 1.3: The structure of nucleosides and nucleotides
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1.2 Fluorescence:
1.2.1 The Fluorescence Process (Fluorescence
Fundamentals)
The process of fluorescence can be illustrated in a simplified diagram
known as the diagram of Electronic Transitions or Jablonski diagram
(Scheme1.1). Jablonski diagram shows that fluorescence is a result of two
stages. The first stage is excitation which occurs when an electron is
excited from the ground state (S0) to a singlet lowest excited state (S1) by
absorption of light (photons). The second stage is relaxation from the
excited state (S1), via different processes involved: Fluorescence occurs
when an electron relaxes from the lowest level of an excited singlet state
(S1) to the singlet ground state (S0). Intersystem crossing occurs when a
photon relaxes from the lowest level of an excited singlet state (S1) to the
triplet excited state (T1). Phosphorescence occurs when a photon is
released from the triplet excited state to the singlet ground state (S0).5

6

1.2.2 Fluorescence Spectroscopy
Fluorescence spectroscopy techniques are methods of analysis that
depend on the fundamental nature of the transitions involved where the
electrons of the analyte are excited to higher electronic states by irradiation
(absorbed photons) at a certain wavelength and emit radiation of a different
wavelength when relaxing back to the ground state.6

Fluorescence spectroscopy techniques have features such as
providing high detection sensitivity, unparalleled time resolution, and can
easily

be

performed

under

several

solution

conditions.7

These

characteristics make them classified as indispensable tools in the study of

7

structure and dynamics of biological molecules

7

and study photophysical

properties of fluorescent molecules, fluorophore (fluorochrome), such as
absorption wavelength λabs, emission wavelength λem, quantum efficiency

φF, and excited state lifetime τ. Each fluorophore has a characteristic light
excitation and emission spectrum where the emission energy is at lower
energy and longer wavelength than the excitation energy.5

1.2.3 Fluorescence Resonance Energy Transfer (FRET):
Förster resonance energy transfer, more commonly known as
Fluorescence resonance energy transfer (FRET),

8

is one of the most

important fluorescence techniques that are utilized widely in biotechnology
measurements, such as single-molecule imaging techniques, probes for
structural and functional analyses, for investigating structure and dynamics
of biopolymers, and molecular beacons.

FRET is not sensitive to the environment, as a result, the information of
fluorescence measurements relate exclusively to the changes in the
conformation of the biopolymer under study.9

8

FRET mechanism (Figure 1.5) , involves two fluorophores, a donor and
an acceptor. Excitation of the donor by absorption of light at one wavelength
results in transfer of energy directly to the acceptor which emits a radiation
at a longer wavelength (Scheme 1.2). This process depends on certain
criteria and requirements that must be met for FRET to occur. The physical
orientation of the transition dipoles of donor and acceptor fluorophores must
be approximately parallel to each other, and the distance between a donor
and acceptor molecule. The effective distance between the donor and
acceptor is in the range of 10–100 Å. In addition, the fluorescence emission
spectrum of the donor and the absorption or excitation spectrum of the
acceptor chromophore must overlap.10

9

A
Adjacent probe
hv

+
FRET

No FRET
B
5'-Nuclease probe
hv

+
FRET

FRET
C
Molecular beacon probe
hv

+

No Contact quenching

Contact quenching
D
Strand displacement probe
hv
+

No Contact quenching

Contact quenching

Scheme 1.5: Overview of energy transfer and fluorescence FRET
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1.3 Fluorescent Nucleotide Analogues
The normal nucleic acid bases provide short decay times (lifetime); as
a result, the natural fluorescence of DNA or RNA is very weak,27 also the
signals are effectively averaged over all the bases in the DNA chain;
consequently, the natural nucleobases do not provide much structural
information. The replacement of a normal base with a modified base can
enhance the emissive properties of the nucleoside.7
Many scientists are interested in synthesizing novel fluorescent
nucleotide base analogues because of

the importance of their utility in

many analytical applications such as detection, quantification of nucleic
acids and study of their structure, dynamics, hybridization, and interaction
with other molecules.11 Therefore, fluorescent nucleic acid base analogues
are very important probes in several fields such as organic chemistry,
physics, biochemistry, and biology.11 Replacing the DNA bases by
fluorescent hydrocarbons and heterocyclic nucleic acid base analogues
helps to predict the location of the molecules.11

11

1.3.1

Classification of Fluorescent nucleobases

I. According to Structure
Fluorescent nucleobases that resembles the natural DNA bases have
several features that make them an important aim for researchers.

12

That

nucleobases which mimic the natural DNA nucleosides are classified into
two groups according to their structure:
(a)

Fluorescent purine analogues,

13

such as 2-aminopurine

(Figure 1.5a), Etheno-A (Figure 1.5b) 3-methylisoxanthopterin
(Figure 1.5c), and 6-methylisoxanthopterine (Figure 1.5d)
(b) Fluorescent pyrimidine analogues,

13

such as furyl-U (Figure

1.6a), pyrrolo-C (Figure 1.6b), 5- benzopyridopyrimidine(Figure
1.6c), and 3,5-diaza-4-oxophenothiazine (tC) (Figure1.6d), bicyclic
4-N-carbamoyldeoxycytidine derivative, pyrrolopyrimidopyrimidine,
and pyrimidopyrimidoindole nucleoside (dCPPI) (figure 1.8).

12

N
N

N

N

N
R

N

N
H

H

N

N
R

N

(a)

(b)

O
'

R

H2N

N
N

NH2
''

N

R

N
R

O

N
R'

3-MI: R'=CH3; R''=H
6-MI: R'=H; R''=CH3

N

N

CH3

N
R

O

DMAP: R'=CH3
6-MAP: R'=H
(d)

(c)

Figure1.5: Fluorescent purine analogs (a) 2-Aminopurine (2-AP), (b) Etheno-A,(c)
3-MI and 6-MI, (d) 6-MAP and DMAP. R=(deoxy)ribose
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II. According to their Environmental Sensitivity
II.I Environmentally Sensitive Fluorescent Base Analogues
Whereas fluorescent nucleobases have great utility as reporters for
enzyme function and as probes of nucleic acid sequence and structure,
some of the fluorescent nucleobases are environmentally sensitive and
influenced by neighboring bases.11

Although several environmentally

sensitive nucleobases have distinctive fluorescent properties and are used
as powerful tools for investigating the perturbations, nucleic acid structure,
dynamics, and recognition, they have some limitations.12,14,15 For instance,
the environment-sensitive fluorescent base analogues could be affected by
neighboring bases and lose their fluorescence, being quenched, during
duplex formation probe. In addition to quenching by neighboring bases they
usually produce low quantum yields.11 These probes can be categorized
as:

isomorphic base analogues, e.g. 2-aminopurine (2AP), pteridines e.g

3-methylisoxanthopterin (3-MI) and 6-methylisoxanthopterin (figure.1.5),
and expanded nucleobases, e.g. pyrrolo-dc (figure.1.7)

and some

fluorescent cytosine analogues developed by Sekine et al (Figure 1.8) and
BDF nucleoside analogues developed by Saito et al. (Figure 1.9) analogues

14

(a) 5-methylpyrimidin-2-one, (b) 7-deazapurines, (c) 5-alkynyluridines, (d )
benzoquinazolines,(e)triazoleadenosines and (f) 1,N6-ethenoadenosine
(Figure 1.10)16

15

16

II.II Environmentally Insensitive Fluorescent Base Analogues
Environment-insensitive fluorescent base analogues are the most
important in experiments that depend on the emission for detection and
where FRET and anisotropy measurements are used
shown

a

high fluorescent

quantum yield

17

when

because they have
incorporated

into

oligonucleotides. Almost all fluorescent nucleobase analogs are quenched
in duplex nucleic acids, whereas it has been demonstrated that the tricyclic
cytosine analogue tC family, phenothiazine, 1,3-diaza-2-oxophenothiazine,
17

and tCO, phenoxazine,1,3-diaza-2-oxophenoxazine (Figure 1.11 a,b) are
fluorescent have shown a high fluorescent quantum yield when incorporated
into oligonucleotides.

18

Also, the non-fluorescent tCnitro (Figure 1.11 c) is

part of tC family consider as an important molecule because it is the first
nucleobase

FRET-pair,

yielding

accurate

distance

and

orientation

information in DNA .19,25,26

1.4 Aims of the Project:
The goals of this project are: to synthesize novel fluorescent nucleoside
analogues that can participate in Watson-Crick hydrogen bonding (Figure
1.12) and afford high brightness, quantum yields (ΦF), high molar extinction
coefficient (ε), and distinguish absorptions. Also, to synthesize different
derivatives of tC for understanding the affects of donor ring substitution at
different positions.
18

R
H
N
H

N

O
H

N
N
R1

N

N

H
R1

H

N

O

O

N
N

Y
N

N

Cytosine

N

N
R1

H

Guanine

N

H
N

N

R1

O
H

Cytosine fluorescent
analogues

H

Guanine

Figure 1.12: Fluorescent nucleoside analogues

Most fluorescent probes that exist today have limitations; for instance,
some

probes

are

very

sensitive

to

the

micro-environment

when

incorporated into an oligonucleotide and will be quenched, as it is
mentioned previously. Also, some fluorescent nucleotides that currently
exist have a fluorophore covalently attached via a flexible linker at C-5 eg.
Cy5-dC, Cy3-dC (Figure 1.13),

24

this flexibility of the linker could displace

the fluorophore from the target position. Moreover, the flexibility impairs the
use of the dye anisotropy, which prevented the direct observation of
conformational rigidity imposed on the nucleobase. The fluorophore
tethered bases have a different size and hydrophobicity compared to the
natural base, thereby precluding their normal interaction with the DNA and
RNA in the cell. Although Cy5 exhibit high red shift excitation at 635 nm and

19

emission at 670–720 nm

22

with high quantum yield when linked to DNA,

they are sensitive to their environment and it is worth mentioning that Cy3
fluorescence is sensitive to not only the closest base, but also to several
additional bases farther away.23

Figure 1.13: Fluorescent base analogues consist of conventional dyes tethered covalently
to the base (e.g. (a) Cy3-dC, (b) Cy5-dC).

The tricyclic fluorescent base analogues tC and tCO (figure 1.11 a,b)
have been reported with unique fluorescence properties; for example, the tC
derivatives are relatively insensitive to neighboring bases because their
fluorescent intensity is virtually not affected by neighbors when it is
incorporated into single and double-stranded oligonucleotides.12 In addition,
they usually generate brightness and quantum yield tCO is around 0.14 –
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0.41, tC 0.219 insensitive when incorporated into single and double-stranded
oligonucleotides.12 Furthermore, these analogs are able to enhance the
stability of oligodeoxynucleotides /RNA duplexes;

18

thus, tC can be useful

for investigating intrinsic characteristics of nucleic acid as well as
interactions between nucleic acids and other molecules.
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Lin, K. et al.

1995, have found that both the phenothiazine and phenoxazine (Figure1.11)
result in greatest duplex stability when tricyclic heterocycles are positioned
together, showing π- π overlap between adjacent aromatic faces which is
not possible in analogs of less than three rings. 18 However, all base-pairing
partners of tC that have been reported such as tC and tCO (Figure 1.11)
have similar absorption and emission wavelengths, so that it is difficult to
distinguish between them. Therefore, we were looking forward to
synthesizing novel modified tC fluorescent nucleoside analogs have higher
brightness, less environmental sensitivity, and have distinguishable
fluorescence emission and absorption wavelengths.

Hypothesis
We have assumed that extended the aromatic surface (extend the π
system) of the natural base, such as the pyrimidine, results in useful
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fluorescent properties. Accordingly, we were looking for synthesizing
pyrimido[4,5-b]quinoline-2(1H)-one ring system tCC derivatives.
Furthermore, according to the fact that photophysical characteristics
(e.g., red shifted absorption and high emission quantum efficiencies)
depend on the structure of the molecule.
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We expected that the functional

groups which allow for extended conjugation of unshared pairs of electrons,
such as alcohol, amine, amide, and ether, would raise the fluorescence
intensity and the quantum yield. Moreover, we have hypothesized that the
position of the substituent would affect the fluorescence intensity, the
absorption, and emission wavelength, and the quantum yield.21
In order to understand the effects of the donor substituent group OCH3,
we reported two new nucleosides, tC8OMe and tC7OMe, that arose from the
design of the tC nucleosides as will discuss in Chapter 3. Although the
tC8OMe and tC7OMe nucleosides arose from the skeleton of the tC
nucleosides, the modification function groups, OCH3, at different positions
7C and 8C would bring different photophysical properties according to the
electronic nature of substituent and the substituent position.
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Chapter 2
Nucleobase analogues with the pyrimido[4,5-b]quinoline2(1H)-one ring system tCC

2.1 Introduction
In this part of our procedure, the main goal was to develop highly
fluorescent nucleotide analogues. We were looking to synthesize the tCC
fluorescent nucleotide with the pyrimido[4,5-b]quinoline-2(1H)-one ring
system (Figure 2.1).

Pyrimidoquinolines derivatives are an important class of heterocyclic
molecules because of their partial similarity to the natural acid bases that
enhances the probability of being able to act as a nucleobase (Figure 2.1).
In general, quinoline molecules have been utilizing extensively in medicinal
chemistry and biomedical field.1,2,6 For instance, they are active

as

antiarrhythmic, antimalarials, antimicrobial, anti-inflammatory, anticancer,1
and analgesic agents.3

As a result of the wide ranging applications of

quinoline derivatives, the synthesis of quinoline derivatives became an
attractive goal for many scientists.
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The intermediate compound 2-chloro-3-formylquinoline was easily
prepared, yet the cyclization of 2-chloro-3-formylquinoline with urea or
guanidine HCl was the most challenging aspect of the synthesis. However,
we have successfully synthesized 2-amino [4,5-b]quinoline-one ring tCC
under super dry reaction conditions with <10 yield.

The tricyclic cytosine nucleobases allow for the formation of two
tautomeric configurations.

4

This tautomerization provides two possible

configurations which are acceptor-acceptor-acceptor (AAA) and donoracceptor-acceptor (DAA) (Scheme 2.1).
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2.2 Synthesis of tCC nucleobase analogues
The reactions sequences were begun with acetanilides, which were
easily converted to 2-chloro-3-formylquinolines by treatment with the
Vilsmeier

reagent.1

Unfortunately,

condensation

of

2-chloro-3-

formylquinoline with urea in a heated solution of acetic acid was not
successful in producing the fluorescent tricyclic tCC analogues pyrimido[4,5b]quinoline-2(1H)-one.

Instead the compound 2-chloro-3-formylquinoline

was hydrolyzed because of water present in the reaction mixture that acts
as a nucleophile and causes substitution at the chlorine atom preventing
coupling with urea (Scheme 2.2).
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2.2.1 Synthesis of tCCOMe nucleobase

In order to synthesize 8-methoxy-pyrimido[4,5-b]quinoline-2(1H)-one
tCC (Figure 2.2.1), the first step was to prepare 3'-methoxy acetanilide (2)
which was obtained by reacting acetic anhydride with m- anisidine in the
presence of pyridine at room temperature.
30

Subsequent synthesis of 2-

chloro-7-methoxy-quinoline-3-carbaldehyde (3) was completed by treatment
of 3’-methoxy acetanilide (2) with dimethylformamide (DMF) and phosphoryl
chloride (Vilsmeier's reagent, VR ).7 Unfortunately, cyclization of (3) with
urea and acetic acid in order to generate the target product 8-methoxypyrimido[4,5-b]quinoline-2(1H)-one tCC (4) did not occur probably because
of water present in the sample that hydrolyzes the intermediate compound
2-chloro-3-formylquinoline preventing the coupling with urea. The scheme
2.2.1 illustrates the attempted synthetic pathway to tCCOMe.
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Scheme 2.2.1: The attempted synthetic pathway to tCCOMe
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O
(3)

2.2.2 Synthesis of tCcex nucleobase

In order to prepare methoxy-tetracyclic cytosine tccex (9) (Figure
2.2.2), the reaction started by preparing 2-naphthylacetamide (6) which was
obtained by reacting acetic anhydride with 2-naphthylamine (5) in the
presence of pyridine at room temperature. The attempt to prepare 2-chloro3-formylnaphthylquinoline (8) by treatment of 2-naphthylacetamide (6) with
dimethylformamide (DMF) and phosphoryl chloride (Vilsmeier's reagent,
VR) produced compound (7) instead of (8) because of the preferred
reactivity of electrophiles at position 8 over the position 2 in quinolines.
Unfortunately, condensation of (7) with urea in a heated solution of acetic
acid was not successful in producing the fluorescent tricyclic analogues
methoxy-tetracyclic cytosine tccex (9).
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2.2.3 Synthesis of tCCOH nucleobase

In order to prepare the molecule tCCOH (Figure 2.2.3) the reaction was
started by preparing acetamide (10) with a protected substituent group. This
was obtained by treatment of 3-acetamidophenol (9) with NaH and methyl
chloromethyl ether (MOMCl) commonly used as a protecting group for
alcohols. Treatment of the acetamide (10) with Vilsmeier's reagent was not
successful in producing the produce (11).
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2.2.4 Synthesis of tCC nucleobase

In order to prepare pyrimido[4,5-b]quinoline-2(1H)-one ring tCC, (16)
(Figure

2.2.4)

the

reaction

was

started

by

formylquinoline (14) from the treatment of

preparing

2-chloro-3-

acetanilide (13) with

dimethylformamide (DMF) and phosphoryl chloride (Vilsmeier's reagent,
VR).

We were able to cyclize the 2-chloro-3-formylquinoline (14) with

guanidine HCl in the presence of sodium hydride base to generate the
target derivative tCC product (16) under super dry conditions with < 10%
yield.
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2.3 Experimental
Synthesis of nucleobase analogues with the pyrimido[4,5b]quinoline-2(1H)-one ring system tCC
General
Solvents and reagents were obtained from commercial suppliers and
used without further purification.

All moisture and oxygen sensitive

reactions were carried out under nitrogen.

Air and moisture sensitive

solvents and solutions of reactions were transferred using syringes.
Reactions were monitored by thin layer chromatography (TLC). NMR
spectra were recorded on Bruker Avance 500MHz spectrometer. Unless
otherwise specified, purifications were performed using manual flash
column chromatography.
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3'-methoxy acetanilide (2).

m-anisidien (1) (44.5mmmol, 5 mL) was added to pyridine (50 mL) in
acetic anhydride (17 mL). The mixture was stirred at room temperature for 3
h. The reaction was quenched by addition of methanol. The crude product
was dissolved in ethyl acetate and washed with 1M HCl (2 x 100 mL) then
with NaHCO3 (2 x 100 mL) then brine (1x 100 mL). The organic layer was
dried over anhydrous Na2SO4. The solvent was evaporated using a rotary
evaporator. Purification via flash column chromatography on silica gel (6%
CH3OH in CH2Cl2) afforded the desired product (2) that was identified via 1H
NMR (6.54 g, 89% yield) (scheme 2.3.1). 1H NMR (500 MHz, Chloroformd, 294 K): δ 7.64 (1 H, s), 7.27 (1 H, s), 7.19 (1 H, t, J 8.1), 6.98 (1 H, dd, J
8.0, 1.9), 6.65 (1 H, dd, J 8.2, 2.5), 3.77 (3 H, s), 2.15 (3 H, s).
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2-chloro-7-methoxy-quinoline-3-carbaldehyde (3).
Dry DMF (5.75 mL) and POCl3 (7.9 mL) were stirred at 0° C under
nitrogen. 3'-methoxy-acetanilide (2) (30.26 mmol, 5 g) was added to the
solution. The reaction mixture was stirred at room temperature 10 min then
heated at 75° C for 4 h. The progress of the reaction was monitored by TLC.
The liquid product was added to ice water generating yellow precipitate that
was collected by filtration and washed with water yielding the desired
product (3) (3.55 g, 53% yield) (scheme 2.3.2).

1

H NMR (500 MHz, DMSO-

d6, 294 K): δ 12.09 (1 H, s), 10.18 (1 H, s), 8.44 (1 H, s), 6.89 (1 H, d, J 8.8,
2.4), 6.84 (1 H, d, J 2.5), 3.86 (3 H, s).
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8-methoxy-pyrimido[4,5-b]quinoline-2(1H)-one tCC base (4).
2-chloro-7-methoxy-3-formylquinoline (3) (4.51 mmol, 1 g) was added
to urea (47.95 mmol, 2.88 g) in acetic acid (20 mL). The mixture was
heated at 80° C for 2 h. The liquid product was added to ice water and then
sodium bicarbonate was added slowly producing orange precipitate that
was collected by filtration and washed with water. Orange fluorescent
powder was the obtained product. Unfortunately, the NMR measurement
shows only the hydrolyzed compound probably because of water present in
the reaction (scheme 2.3.3).
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2-naphthylacetamide (6).
2-naphthylamine (5) (6.26mmol, 0.9 g) was stirred in acetic anhydride
(2.3 mL) in the presence of pyridine (7.1 mL) at room temperature for 3 h.
Methanol was added to quench the reaction. The crude product was
dissolved in ethyl acetate and washed with 1M HCl (2 x 100 mL) then with
NaHCO3 (2 x 100 mL) then brine (saturated NaCl 1x 100 mL) .The organic
layer was dried over anhydrous Na2SO4, and the solvent was removed by
evaporation. Purification via flash column chromatography on silica gel (6%
CH3OH in CH2Cl2) afforded the desired product (6) (0.8296 g, 71.5% yield)
(scheme 2.3.4). 1H NMR (500 MHz, Chloroform-d, 294 K): δ 8.19 (1 H, s),
7.77 (4 H, dd, J 7.3, 4.6), 7.45 (2 H, ddd, J 8.1, 4.2, 1.9), 7.39 (1 H, s), 2.23
(3 H, s).
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2-chloro-3-formylnaphthylquinoline (8).
Dry DMF (0.72 mL) and POCl3 (2.5 mL) were stirred at 0° C under
nitrogen. 2-naphthylacetamide (6) (4.427 mmol, 0.829 g) was added to the
solution and the reaction mixture was stirred at room temperature for 10
min. Then the mixture was heated at 75° C overnight. Then the liquid
product was added to ice water generating precipitate.

The orange

precipitate was collected by filtration and washed with water. Purification via
flash column chromatography on silica gel (15% ethyl acetate in hexanes
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then 30% ethyl acetate in CH2Cl2) resulted in the desired product (7) which
was collected and concentrated by evaporating the solvent with a rotary
evaporator (0.879 g, 72% yield) (scheme 2.3.5).

1

H NMR (500 MHz,

Chloroform-d, 294 K): δ 10.64 (1 H, s), 9.51 (1 H, s), 8.71 (1 H, d, J 8.3),
8.17 (1 H, d, J 9.1), 8.00 (1 H, d), 7.96 (1 H, d, J 9.2), 7.81 (1 H, t, J 8.0),
7.75 (1 H, t, J 7.5).

Methoxy-tetracyclic cytosine tcCex (9).
2-chloro-3-formyl naphthyl quinoline (7) (0.413mmol, 0.1g) was added to
urea (0.413 mmol, 0.028) in (2 mL) acetic acid. The mixture was heated at
80° C 2 h. The liquid product was added to ice water and then sodium
bicarbonate was added producing an orange precipitate that was collected
43

by filtration and washed with water. Orange fluorescent powder was
obtained (Scheme 2.3.6). Purification was performed via flash column
chromatography on silica gel (4% methanol in CH2Cl2), but 1H NMR (500
MHz, CDCl3) measurements showed the target product tCCex was not
produced.

acetamide with protected group (10).
3-acetamidophenol (9) (6.6 mmol,1g) was added to

NaH (7.25

mmol,0.174 g) dissolved in THF (20.6 mL) at 0°C under nitrogen. After 3 h,
MOMCl (0.5 mL) was added at 22° C overnight. Purification via flash column
chromatography on silica gel (4% methanol in dichloromethane) resulted in
the desired product (10) (1.098 g, 76.5% yield) (Scheme 2.3.7). 1H NMR
(500 MHz, Chloroform-d, 294 K): δ 8.35 (1 H, s), 7.15 (1 H, d, J 1.7), 7.14
(1 H, d, J 1.2), 6.74 – 6.70 (1 H, m), 5.26 (1 H, s), 5.11 (1 H, s), 3.42 (3 H,
s), 2.11 (3 H, s).
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protected 2-chloro-3-formylquinolines(11).
Dry DMF (1.14 mL) and POCl3 (3.93 mL) were stirred at 0° C under
nitrogen. acetanilide (10) (6.034 mmol, 1.178 g) was added to the solution
and the reaction mixture was stirred at room temperature for 10 min. Then
the mixture was heated at 75° C for 4 h. The progress of the reaction was
monitored by TLC. The liquid product was added to ice water and then
sodium bicarbonate was added producing an orange precipitate that was
collected by filtration and washed with water. Orange fluorescent powder
was obtained. Purification was performed via flash column chromatography
on silica gel (6% methanol in dichloromethane) but the 1H NMR (500 MHz,
CDCl3) (Scheme 2.3.8) measurements showed the target product (11) was
not produced.
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2-chloro-3-formylquinoline (14).
Acetanilide (13) (24 mmol, 3.24 g) was added to a stirred solution of
POCl3 (16 mL) in dry dimethylformamide, DMF,

(4.6 mL) at 0°C under

nitrogen. After 10 min stirring at room temperature the mixture was heated
at 75°C for 16h. The progress of the reaction was monitored by TLC. Then
the liquid product was added to ice water and was neutralized by adding
potassium carbonate generating yellow precipitate (14) in (2.94 g, 64%
yield) (Scheme 2.3.9).
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2-amino -pyrimido[4,5-b]quinoline-one ring tCC(16).
To a stirred solution of guanidine HCl (0.96mmol, 0.09 g) in DMF (2 mL)
over molecular sieves sodium hydride 60% in oil (0.64 mmol, 0.026 g) was
added. After 60 min 2-chloro-3-formylquinoline (0.16 mmol, 0.03 g) (14)
was added and the mixture was heated at 80° C for 1 h. The precipitate
produced was filtered and washed with 1:1 CH3OH: CH2Cl2. The purification
via flash column chromatography on silica gel (20% methanol in
dichloromethane) afforded the desired product 2-amino-tCC (16) (<10 %
yield) (Scheme 2.3.10).

2.4 Conclusion:
Since there are published papers that show how easy the synthesis of
tCC fluorescent nucleotide is with the pyrimido[4,5-b]quinoline-2(1H)-one
ring system,1 we spent a long time attempting to prepare tCC derivatives.
We exactly followed some published procedures; however, using urea in
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heated acetic acid for the cyclization reaction of 2-chloro-3-formylquinoline
failed even under super dry conditions as the hydrolysis of 2-chloro-3formylquinoline takes place instead of the cyclization. Fortunately, using
guanidine HCl in the last reaction for the cyclization worked as the
nucleophile is stronger than urea because of the unshared pair of electrons
on the nitrogen atom which gives more of a chance for the cyclization to
occur instead of hydrolysis.

We have successfully synthesized 2-amino

[4,5-b]quinoline-one ring tCC under super dry reaction conditions with low
yield <10%.

48

2.5 References
1. Chandra, A., Upadhyay, S., Singh, B., Sharma, N., Singh, N.
Tetrahedron. 2011, 67, 9219-9224.
2. Selvi, S. Nadaraj, V. Mohan, S. Sasi, R. Hema, M. Bioorg. Med. Chem.
2006, 14, 3896–390.
3. Ali, S., Li,Y., Anwar, S., Yang, F., Chen, Z., Liang, Y. J. Org.
Chem., 2012, 77, 424–431.
4. Stengel, G., Purse, B., Wilhelmsson,M., Urban, M., Kuchta,R.
Biochemistry. 2009, 48, 7547–7555.
5. Taylor, E. C., Kalenda, N. W. J. Am. Chem. Soc. , 1956, 78, 5108-5115.
6. Shestakova, A. S., Sidorenkoa, O. E., Bushmarinovb, I. S., Shikhalieva,
Kh. S., Antipinb,M. Yu. J. org. Chem. 2009, 45,1691−1696.
7. Methcohn, O., Narine, B., and Tarnowski, B.J. Tetrahedron Letters.1979,
33, 3111 - 3114.

49

Chapter 3

Synthesis and photophysical characterization of tC nucleoside derivatives

3.1 Introduction
In this part of our procedure, we have designed two new fluorescent
nucleosides analogues tC8OMe, tC7OMe (Figure 3.1.1); in addition we
evaluated some of their photophysical properties as compared to
Matteucci’s phenothiazine (tC).2 Moreover, we were looking for an improved
synthetic route to prepare the non fluorescent nucleobase tCnitro which is
considered to be an important molecule that uses as acceptor in FRET
process.4,8
As stated previously (in chapter 1), this project aimed to obtain a set of
fluorescent nucleoside analogues that closely resemble cytosine by
extending the aromatic surface (extended conjugation) to enhance the
photophysical properties.1 In addition to synthesizing new fluorescent

50

nucleoside analogues and evaluating their photophysical properties, this
project aimed

to understand the effects of donor substituent on the

photophysical properties of tC.
We are interested in synthesizing new fluorescent nucleoside tC
derivatives because of the unique properties of the tC family. For example,
the size and structure of tC analogues enable them to be incorporated sitespecifically into nucleic acids with minimal disturbance of the native
structure. Furthermore, tC analogues have shown their emission quantum
and yield to be insensitive to changes in close bases after being
incorporated into oligonucleotides.

2

Consequently, tC is significantly more

useful for distance determinations than the other available fluorescent base
analogues which have sensitive emission and quantum yields.5 However,
tricyclic cytosine tC analogues have exhibited relatively low quantum yields
around 0.2 for the tC analogue

5,8

and around 0.14 – 0.41 for tCO.

9

As a

result, we were looking to improve the quantum yield by introducing tC
derivatives which have a heteroatom -containing substituent such as a
methoxy group.
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These substituents allow for extended conjugation of unshared pairs of
electrons leading to high fluorescence quantum yields, and red-shifts in
emission spectra. Also, we have studied the effect of the position of the
substituents.
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Figure 3.1.1: Fluorescent nucleoside analogues (1) tC, (2) tC8OMe , (3) tC7OMe, (4) tCnitro

In order to provide novel structures that result in excellent
photophysical properties for use as probes, we have designed modified
novel nucleosides that are similar to the core structure of Matteucci´s
phenothiazine (tC)2 nucleoside with substituted electron donor group,OCH3,
which allows for extended conjugation of unshared pairs of electrons, at
different positions 7C and 8C. These different substitution positions offer
important distinctions between the design of the tC, tC8OMe, and tC7OMe. The
tC nucleoside without any addition functional groups was easy to
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synthesize. In contrast, the synthetic strategy for the tC7OMe nucleoside that
has a functional group OCH3, substitution para to the amine group
synthetically less challenging and higher yielding than synthesis of tC8OMe
which has the OCH3 group substitution meta to the amine group. However,
the fluorescence emission wavelength of tC8OMe shifted farther than the
fluorescence emission wavelength of both tC and tC7OMe.

3.2 General Synthetic Elaborations:
In general, the synthesis of fluorescent nucleobase analogues of the
tricyclic cytosine (tC) family was convergent and was carried out in four
main steps (scheme 3.2.1) (a) coupling, (b) ring-closure, (c) glycosylation,
and (d) hydrolysis, which will be clearly explained for each synthesis.
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Scheme 3.2: Synthetic Elaboration of Fluorescent nucleoside analogues tC
(a) coupling, (b) ring-closure, (c) glycosylation, (d) hydrolysis

3.2.1 Synthesis of tC nucleoside
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O

The fluorescent tC nucleoside, Matteucci´s phenothiazine, (Figure
3.2.1) was synthesized in four steps (Scheme 3.2.1). The intermediate (3)
and tC base (4) were synthesized using the same pathway that has been
used in an article which was published by Wilhelmsson and coworkers.5
Beginning with the combination of 5-bromouracil (2) with 2-aminothiophenol
(1) heated in ethylene glycol in the presence of Na2CO3 for 1 h generated
62%

yield (3).

Followed by the ring-closure step that was started by

heating the product (3) in a solution of EtOH and HCl for 22 h produced tC
base (4) in 73 % yield. For the glycosylation, using sodium hydride (60% in
mineral oil), which is a strong base, deprotonated O-H giving an alkoxide
anion (R-O- Na+) salt, which has limited solubility in DMF. In this case, the
glycosylation reaction has the chance to occur at the anion oxygen as well
as at the nitrogen in position 2, the yield of 3-(2-Deoxy-b-D-ribofuranosyl)1,3-diaza-2-oxophenothiazine was poor ~ 10–15%.5

We were able to

increase the glycosylation yield to 40% for a mixture of β and α anomeric
2´-deoxy-3´,5´-di-O-p-toluoyl-phenothiazine (5) by using the same pathway
which

was

published

in

an

article

by

Leconte.6

Using

the

Bis(trimethylsilyl)acetamide we were able to protect the oxygen on the tC
base (silylation of alcohol) thus, the glycosylation reaction was directed
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solely toward N-2 and the coupling was achieved in 40% yield.

The

separation of individual β and α anomers is poor at this step, thus the
anomeric mixture was carried through to the next step. Toluoyl deprotection
of the toluoylated phenothiazine (5) was achieved by using sodium
methoxide in methanol for a combined yield of 0.0685 g, 43 %. The free
nucleosides were isolated separately β (6) and α (7) and identified
depending on the elution profile from automated chromatography using an
Isco gradient (CombiFlash® Rf ) and confirmed via 1H NMR 500.
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3.2.2 Synthesis of tC8OMe nucleoside

Synthesis of the tC8OMe nucleoside (Figure 3.2.2) was carried out in six
steps (Scheme 3.2.2). In order to prepare the starting material 2-amino-4methoxythiophenol (10), the reaction was started with heating 5-methoxy-2methylbenzothiazole ethylene glycol and NaOH under nitrogen gas.
Unfortunately, the resulting mixture contained more disulfide (9) than the
target product 2-amino-4-methoxythiophenol (10). However, purification and
isolation of the disulfide (9) produced just ~ 5% yield pure material. So we
changed the procedure in order to improve the yield of the disulfide (9) by
adding

H2O2.

1-(4-methoxy-2-aminothiophenol)-4-methoxy-2-

aminothiophenol disulfide, (9) was successfully reduced to generate 2amino-4-methoxythiophenol (10). Reduction was done by treating it with
dithiothreitol, DTT, or triphenylphosphine, PPh3. Using triphenylphosphine
58

produced triphenylphosphine oxide which is not easy to isolate from the
target product, whereas using DTT enabled reduction of the disulfide bond
and easy access to the intermediate 2-amino-4-methoxy-thiophenol (10). It
may be useful to reduce the disulfide bond with PEt3 which was useful in
reducing the disulfide bone in tC7OMe preparation (see below), but we did not
try using PEt3 with this molecule. By adding 5-Bromouracil and Na2CO3 into
the previous mixture and heating at 120° C, coupling was achieved, yielding
product (11) in 33% yield. The attempted synthesis of tC8oMe base (12)
using the same pathway that was used in an article published by
Wilhelmsson and coworkers

7

which is, heating the product (11) in EtOH

and HCl solution at 80° C for 44 h produced product (12) in low yield ~ 5%.
Fortunately, we have improved the yield to 30 % by changing the solvent to
butanol instead of ethanol , thus we were able to heat the reaction at 116°C
for 20 h generating the tC8OMe base (12) in 30% yield. For the glycosylation
and for hydrolysis of toluoyl groups, we have used the same pathway that
was previously used by Leconte.6 The tC8OMe base (12) was coupled to
3´,5´-bis(toluoyl)-2-deoxyribosyl in the presence of Bis(trimethylsilyl)acetamide to protect the oxygen on the tC8OMe base (silylation of alcohol).
Thus, the glycosylation reaction was directed only toward N-2 of compound
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(12) producing a mixture of β and α anomers of

2´-deoxy-3´,5´-di-O-p-

toluoyl- 8-methoxy-phenothiazine (13) in 40% yield. The separation of β
and α is poor at this step, thus the anomeric mixture was carried through to
the next step. Toluoyl deprotection of the toluoylated 8-methoxyphenothiazine (13) was achieved by using sodium methoxide in methanol,
and the free nucleoside were isolated separately β (14) and α (15),
identified depending on the elution profile from automated chromatography
using Isco gradient (CombiFlash® Rf ) (100:0 →60:40, CH2Cl2: MeOH) then
confirmed via 1H NMR 500. The β & α combined yield is 0.042 g, 34%.
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3.2.3 Synthesis of tC7OMe Nucleoside
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Figure3.2.3: The fluorescent tC7OMe nucleoside

Synthesis of the tC7OMe nucleoside (Figure 3.2.3) was carried out in six
steps (Scheme 3.2.3). In order to prepare the starting material 2-amino-5methoxythiophenol (18), synthesis was first attempted using the same
Wilhelmsson procedure using NaOH in ethylene glycol and heating at 120
°C, that had been used previously for preparing the tC8OMe base, but this
produced a polymeric material, which we did not characterize. As a result,
we changed the procedure by heating 6-methoxy-2-methylbenzothiazole in
hydrazine monohydrate followed by oxidation of the sulfide molecule by the
addition of hydrogen peroxide after cooling the reaction down to room
temperature. The disulfide (17) was successfully reduced to generate the
intermediate 2-amino-5-methoxythiophenol (18) by treating it with either
triethylphosphine in 1M tetrahydrofuran, PEt3, or triphenylphosphine. Using
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triphenylphosphine produced triphenylphosphine oxide which is not easy to
isolate from the target product, whereas using PEt3 we were able to reduce
the disulfide bond easily and this gave access to the intermediate 2-amino5-methoxythiophenol (18). By adding 5-Bromouracil and Na2CO3 into the
previous mixture and heating at 120°C, coupling was achieved, yielding
product (19) in 35% yield. First attempts to synthesize the tC7OMe base (20)
were made by using the same pathway that had been used previously for
the tC8OMe base by addition of HCl immediately to the mixture of starting
material and butanol at room temperature then heating the mixture at
160°C. This procedure did not produce any reaction because the starting
material had limited solubility. As a result, we changed the pathway by
stirring compound (19) in butanol at 100°C for 10 min; in order to more
completely the dissolve product (19) then added HCl after cooling the
mixture down to room temperature for 5 min. The coupling was achieved by
heating the reaction mixture at 116 °C overnight, an orange precipitate was
generated which became yellow after washing with water yielding 61%.
tC7OMe base (20). No further purification was necessary for the tC7OMe base
(20) which has been confirmed by NMR).
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For the glycosylation and for the hydrolysis of toluoyl groups, we have
used the same pathway that previously was used by Leconte.6 The tC7OMe
base (20) was coupled to 3´,5´-bis(toluoyl)-2-deoxyribosyl in the presence of
Bis(trimethylsilyl)acetamide that was able to protect the oxygen on the
tC7OMe base (silylation of alcohol) thus, the glycosylation reaction was
directed only toward the N-2 of compound (20) producing mixture of β and α
anomers of 2´-deoxy-3´,5´-di-O-p-toluoyl- 7-methoxy-phenothiazine (21) in
47% yield. The separation of β and α anomers is poor at this step, thus the
anomeric mixture was carried through to the next step. Toluoyl deprotection
of the toluoylated 7-methoxy-phenothiazine (21) was achieved by using
sodium methoxide in methanol, and the free nucleoside anomers were
isolated separately β (22) and α (23) were identified depending the elution
profile

from

automated

chromatography

using

an

Isco

gradient

(CombiFlash® Rf 100:0 → 60:40, CH2Cl2: MeOH) then confirmed via 1H
NMR 500 and MS analysis.The combined yield of β & α was 0.0057g,67 %.

64

65

3.2.4 Synthesis of tCnitro Nucleobase

NO2

S
HN
N

NH
O

Figure3.2.4: The tCnitro nucleobase

tCnitro nucleobase (Figure 3.2.4) which was reported by Börjesson in
2009 as the first base analogue FRET acceptor

4

, was synthesized in four

steps are shown in Scheme (3.2.4). Unfortunately, using the same pathway
that has been used in an article that was published by Börjesson4 for the
synthesis of this compound (27) generated a poor yield of around 12 %.
This was the result of most of product oxidizing the starting material and
thus producing a disulfide bond between two 5-nitro-2-aminothiophenol
molecules. In order to improve the yield, a disulfied bond between two 5nitro-2-aminothiophenol molecules was used as the starting material for the
synthesis yielding product (27). The ring of 6-Nitrobenzothiazole (24) was
opened by the addition of hydrazine monohydrate in ethanol and heating at
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100 °C for 18h then the reaction was exposed to oxygen in the fume hood
to oxidize the sulfur which generated a disulfide bond between two 5-nitro2-aminothiophenol

molecules,

1-(5-nitro-2-aminothiophenol)-5-nitro-2-

aminothiophenol (25). Reducing the disulfide bond was accomplished
immediately via either DTT, PPh3 ,or Et3P.

Using triphenylphosphine

produced triphenylphosphine oxide which is not easy to isolate from the
target product, whereas using DTT or PEt3 we were able to reduce the
disulfide bond easily and this gave access to the intermediate 5-nitro-2aminothiophenol (26).

By adding 5-Bromouracil and Na2CO3

into the

previous mixture and heating at 120° C for 17 h coupling was achieved
yielding product (27). The synthesis of the base tCnitro (28) was the most
challenging that we faced in the course of this lab work. The synthesis using
the same pathway that has been used in an article that was published by
Börjesson4 did not show any reaction even after heating the mixture at 116°
C for two days. Also, there was no progress of the reaction after heating the
mixture at 127° C for ~ 48h. Fortunately, the synthesis of the base tCnitro (28)
was achieved by using the same pathway that has been used previously for
synthesizing the tC8OMe base but by heating product (27) in butanol at a
higher temperature (170° C) for 3 days producing a crude mixture containing
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the target product (28) as was confirmed via mass spectral analysis. We did
not try to purify the product yet, but someone from the group will do so in
order to glycosylate the pure base and continue this analog synthesis.
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3.6 Photophysical properties of the fluorescent
nucleosides
To understand the effects of the donor substituent group and their
positions on the photophysical properties of the tC derivatives, and also to
explore whether the features of the fluorescent nucleosides tC derivatives
make them ideal for utilization as probes, and for further use in FRET
experiments, the photophysical properties of the fluorescent nucleosides tC
derivatives have been investigated.

3.6.1 The Absorption of tC, tC8OMe, tC7OMe:

Figure 3.6.1shows the normalized absorption spectra of the tC, tC8OMe,
and tC7OMe nucleoside analogues as a dilute solution in Ethanol (~10µM).
The tC8OMe analogue, shows a red shift absorption that peaks at
approximately 377 nm whereas the tC7OMe spectrum appears as two peaks
one at approximately 325 nm and an unclear peak at approximately 374
nm, and the tC shows absorption that peaks at approximately 371 nm. On
the other hand, the spectra of the absorption measurements of the tC
nucleoside derivatives as dilute (~10 µM) solutions in water shows that the
tC8OMe is the most red shifted absorption that peaks at 381 nm while the
tC7OMe spectrum shows two peaks at approximately 327 nm and 376 nm,
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and the tC shows absorption maximum at 377 nm. Consequently, the
absorption of each nucleoside, tC, tC8OMe, and tC7OMe, is minimally sensitive
to changes in solvent polarity as is clear in table 3.6.1.

Figure 3.6.1: The normalized absorption spectra of tC, tC8OMe, and tC7OMe in EtOH and in
H2O

3.6.2 The Fluorescence Emission and Excitation of tC
derivatives:
Figure 3.6.2a shows the normalized excitation and emission spectra of
the tC, tC8OMe, and tC7OMe nucleosides in ethanol. Upon excitation at 381nm
of a dilute solution (10 µM) in ethanol, the nucleoside tC8OMe displays an
emission that peaks at ~518 nm. On the other hand, the nucleosides tC7OMe
and tC exhibit shorter emission wavelengths that peak at ~498 nm, and
~483 nm respectively.
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The emission measurements were made with different concentrations
(between 1µM to 5 µM) in EtOH for each nucleoside and the emission
wavelengths were: tC 485.07-488.05 nm, tC8OMe 512.98 - 509.85 nm, and
tC7OMe 494.09-499.09 nm
Figure 3.6.2b shows the normalized excitation and emission spectra of
the tC, tC8OMe, and tC7OMe nucleosides in ethanol. A dilute solution (10 µM)
in water, the nucleoside tC8OMe displays an emission that peaks at ~536 nm.
On the other hand, the nucleosides tC7OMe and tC exhibit shorter emission
wavelengths that peak at ~517 nm, and ~501 nm respectively.

Figure 3.6.2a: The excitation and emission spectra of tC, tC8OMe, tC7OMe nucleosides in
Ethanol (conc. 10µM)
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Figure 3.6.2b: The excitation and emission spectra of tC, tC8OMe, tC7OMe nucleosides in
H2O (conc. 10µM)

Nucleoside

Solvent

λem nm

λabs nm

tC

H2O

501.9

377

tC

EtOH

482.9

371

tC7OMe

H2O

517.0

376 & ~ 327

tC7OMe

EtOH

497.8

374 & 325

tC8OMe

H2O

536.9

381

tC8OMe

EtOH

517.9

377

Table 3.6.1: Absorption and Fluorescence emission maxima of tC derivatives
in H2O and in EtOH

3.6.3 Quantum yields
Quantum yields were determined using anthracene (ΦF=0.27 in
ethanol) as a standard

7

for comparison to the nucleosides tC, tC8OMe, and

tC7OMe. The quantum yields of all nucleosides (tC, tC8OMe, and tC7OMe) were
determined using the following equation:
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φX = φS[GradX /GradS]

X/

Equation

S

1
Where ΦX is the unknown quantum yield of tC the nucleoside analogue. ΦS
is the quantum yield of anthracene. Grad is the slope from the plot of the
integrated fluorescence intensity versus the absorbance at the excitation
wavelength.

X=

S

is the refractive index of the solvent (1.36 for ethanol ).

The nucleosides tC8OMe, tC7OMe and tC exhibits fluorescence quantum yields
in etanol of φF = 0.43, 0.86, 0.17 respectively.

Figure 3.6.3a: Plot of integrated emission versus absorption to
determine the quantum yield of tC
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Figure 3.6.3b: Plot of integrated emission versus absorption to
determine the quantum yield of tC8OMe

Figure 3.6.3c: Plot of integrated emission versus absorption to
determine the quantum yield of tC7OMe

3.6.4 Molar Extinction Coefficients:
The molar extinction coefficients of all nucleosides (tC, tC8OMe, and
tC7OMe) were measured using a Varian Cary 100 Bio Spectrophotometer,
and determined using the Beer’s Law equation:
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Aλ = εcL = εc when L = 1 cm

Equation 2

Where, ε: molar absorptivity, A: absorbance, and c: molar concentration.
The molar absorptivities for tC, tC8OMe, and tC7OMe were calculated via the
slop of a plot of absorption versus concentration (Figure 3.7.4) to be 8300
M-1 cm-1, 5200 M-1 cm-1 and 5400 M-1 cm-1 respectively.

Figure 3.6.4: Plot of absorption versus concentration for tC analogues
From the molar absorptive we can calculate another quantification of the fluorescence
which is brightness.
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Brightness = ε x φF
Nucleoside

Solvent

Equation 3
Quantum
Yield in EtOH

Molar
absorptive
(M)-1 cm-1

Brightness
(M)-1 cm-1

tC

EtOH

0.17

8300

1411

tC8OMe

EtOH

0.43

5200

2080

tC7OMe

EtOH

0.86

5400

4644

Table 3.6.2: Fluorescence quantum yields, molar absorptivity, and brightness in EtOH

3.7 Experimental
Synthesis of tC nucleoside analogue derivatives and the
nucleobase tCnitro
General
Solvents and reagents were obtained from commercial suppliers and
used without further purification. All moisture and oxygen sensitive reactions
were carried out under nitrogen. Air and moisture sensitive solvents and
solutions of reactions were transferred by syringe. Reactions were
monitored by thin layer chromatography (TLC). NMR spectra were recorded
on a Bruker Avance 500MHz spectrometer. UV-Vis absorption spectra were
recorded on a Varian Cary 100 Bio Spectrophotometer, and fluorescence,
excitation, and emission spectra were recorded on a Varian Cary Eclipse
Fluorimeter. Mass spectra were measured at the Central Analytical
Laboratory at the University of Colorado at Boulder. Unless otherwise
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specified, purifications were performed using Teledyne Isco advanced
automated chromatography CombiFlash ® Rf with ultra pure flash column
silica gel.
O
SH
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HO
O

N
H
(2)

NH2

O

Br

HN

OH
HN

Na2CO3 / 120°C
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S
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62%

N
H
(3)

Scheme 3.7.1: The synthesis of 2,4-Dihydroxy-5-(2-amino-phenylthio)pyrimidine

2,4-Dihydroxy-5-(2-amino-phenylthio)pyrimidine(3).
2-aminothiophenol (1) (22.33 mmol, 2.8 g) was dissolved in ethylene
glycol (10 mL) under nitrogen gas. 5-bromouracil (2) (16.6 mmol, 3.16 g)
and Na2CO3 (16.6 mmol, 1.76g) were added to the solution. The mixture
was heated at 120° C for an hour then was allowed to cool to room
temperature before adding water (30 mL) then the reaction was neutralized
by dropwise addition of ~2 mL acetic acid pH indicator paper was used to
check that the neutralization was complete and the pH of the mixture was 7.
A yellow precipitate was collected via filtration and washed first with water
and then ethanol until the precipitate had become colorless. The precipitate
was finally washed with a small volume of ether to facilitate drying. The
precipitate was dissolved in warm 0.02 M Sodium hydroxide (33 mL)
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warmed to ~50° C then the mixture was neutralized to pH ~7 with acetic
acid. The mixture was filtered and the white precipitate was washed first
with water, then with ethanol and finally with ether. A white precipitate
formed which was product (3) (2.2 g) in 62% yield. 1H NMR (500 MHz,
DMSO-d6, 294 K): δ 11.36 (1 H, s), 11.16 (1 H, s), 7.53 (1 H, d, J 1.6), 7.31
(1 H, dt, J 7.7, 1.7), 7.08 – 7.03 (1 H, m), 6.70 (1 H, dt, J 8.2, 1.5), 6.50 (1
H, tt, J 7.4, 1.6), 5.52 (2 H, s).

1,3-diaza-2-oxophenothiazine (tC base) (4).
2,4-Dihydroxy-5-(2-amino -phenylthio)pyrimidine (3) (3.625 mmol, 0.853
g)

was stirred in ethanol (17.3 mL)

then HCl (1.73 mL) was added

dropwise. The reaction mixture was stirred at 80 °C for 22 h. The reaction
mixture was cooled to room temperature and filtered. The precipitate was
added to a stirred, warm (50 °C) aqueous 5% ammonia solution. After 5 min
the solution was filtered. This washing procedure was repeated twice. The
yellow product was finally washed with water and left to dry overnight to
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yield compound (4) in 0.575 g, 73% yield. 1H-NMR (500 MHz, DMSO-d6,
294 K): δ 10.24 (1 H, s), 7.42 (1 H, s), 7.10 – 7.00 (2 H, m), 6.92 (2 H, d, J
8.0).

2´-deoxy-3´,5´-di-O-p-toluoyl-phenothiazine(5).
1,3-diaza-2-oxophenothiazine (tC base) (4) (0.299 mmol, 0.065 g) was
stirred in anhydrous acetonitrile (1.4 mL, 99%) for 10 min at room
temperature under nitrogen. Bis(trimethylsilyl)acetamide (0.102 mL) was
added to the solution. After 40 min of stirring at room temperature 3´,5´bis(toluoyl)-2-deoxyribosyl chloride (0.383 mmol, 0.149 g) was added at 0
ºC followed by (6 µl ) SnCl4 dropwise.

After 4 h, 2´-deoxy-3´,5´-di-O-p-

toluoyl-phenothiazine (5) was generated. The progress of the reaction was
monitored by TLC. The mixture was diluted with ethyl acetate (8 mL) and
the resulting solution was washed with saturated NaHCO3 (3x20 mL) and
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brine (1x20 mL). The organic layer was dried over anhydrous Na2SO4, and
concentrated using a rotary evaporator. Purification via flash column
chromatography on silica gel (CH2Cl2: MeOH, 100:0 → 0:100) afforded the
desired product (5) in a mixture of α and β anomers, 0.068g, 40 % yield.
1

H NMR (500 MHz, Chloroform-d, 294 K): δ 7.92 – 7.88 (3 H, m), 7.76 –

7.70 (1 H, m), 7.43 (1 H, d, J 12.4), 7.07 (1 H, dd, J 8.0, 7.1, 1.8), 7.00 –
6.97 (3 H, m), 6.93 – 6.89 (1 H, m), 6.86 (1 H, dd, J 8.0, 1.2), 6.36 (1 H, dd,
J 8.2, 5.6), 6.30 (1 H, dd, J 6.7, 1.1), 5.64 – 5.57 (2 H, m), 5.53 (1 H, dd, J
8.1, 6.2, 1.9), 4.88 (1 H, t, J 4.3), 4.78 (1 H, dd, J 12.2, 3.0), 4.66 (1 H, dd, J
12.3, 3.3), 4.59 (1 H, q, J 2.9), 4.55 – 4.51 (2 H, m), 4.45 – 4.40 (1 H, m),
3.49 (1 H, s), 2.99 – 2.88 (2 H, m), 2.62 (1 H, d, J 15.4), 1.98 (2 H, d, J
18.7).
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3-(2-Deoxy-b-D-ribofuranosyl)-1,3-diaza-2-oxophenothiazine
(6)&(7).
2´-deoxy-3´,5´-di-O-p-toluoyl-phenothiazine (5) (0.478 mmol, 0.159 g)
was dissolved in (5 mL) absolute methanol at room temperature. NaOMe
(30% wt. 5.4 M, 99% in methanol) (0.1mL) was added dropwise to the
solution. The progress of the reaction was monitored by TLC. After 30 min
the reaction was complete, and drops of acetic acid were added to quench
the reaction. The solvent was removed by evaporation using a rotary
evaporator. Purification via flash column chromatography on silica gel
(CH2Cl2: MeOH, 100:0 → 45:55) afforded free isolated nucleoside anomers
β (6) and α (7) that were identified depending on the elution profile from
automated chromatography using an Isco gradient (CombiFlash® Rf ) and
confirmed via 1H NMR 500. The combined yield is 0.0685 g, 43 %.

β-anomer
1

H NMR (500 MHz, Methanol-d4, 294 K): δ H (500 MHz, Methanol-d4)

7.93 (1 H, s), 7.91 – 7.86 (1 H, m), 7.26 (1 H, d, J 8.0), 7.07 (1 H, td, J 7.7,
1.5), 6.99 (1 H, dd, J 7.9, 1.5), 6.96 – 6.92 (1 H, m), 6.85 (1 H, dd, J 8.1,
1.1), 6.18 (1 H, t, J 6.3), 4.36 (1 H, dt, J 6.4, 4.0), 3.93 (1 H, q, J 3.5), 3.81
(1 H, d, J 3.1), 3.74 (1 H, d, J 3.6), 2.40 (2 H, s), 2.14 (1 H, dt, J 13.3, 6.5).
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α-anomer
1

H (500 MHz, Methanol-d4, 294 K) δ 7.69 (1 H, s), 7.10 – 7.03 (1 H,

m), 7.00 (1 H, dd, J 7.8, 1.5), 6.94 (1 H, td, J 7.5, 1.3), 6.86 (1 H, d, J 1.3),
6.84 (1 H, d, J 1.3), 6.09 (1 H, dd, J 7.2, 2.1), 4.35 – 4.30 (3 H, m), 3.63 –
3.55 (3 H, m), 2.70 – 2.62 (1 H, m), 2.08 (1 H, dt, J 14.6, 2.1).

1-(4-methoxy-2-aminothiophenol)-4-methoxy-2-amino-thiophenol(9).
5-methoxy-2-methyl benzothiazole (8) (5.57mmol, 1g) was dissolved in
ethylene glycol (6 mL) under nitrogen gas. NaOH (6 mL, 10 M) was added
and the mixture was heated at 125°C overnight. Unfortunately, the product
mixture contained more 1-(4-methoxy-2-aminothiophenol)-4-methoxy-2aminothiophenol without nitrogen gas followed by the addition of H2O2 after
cooling of the reaction to room temperature to increase the chance of
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oxidizing

the

sulfur

bond.

The

yellow

product

1-(4-methoxy-2-

aminothiophenol)-4-methoxy-2-aminothiophenol, disulfide (9) was isolated
via flash column chromatography on silica gel (CH2Cl2: MeOH, 100:0 →
95:5) in 0.859 g, 68% yield, which is more than the target product 2-amino4-methoxythiophenol (10) 1H NMR (500 MHz, DMSO-d6, 294 K): δ 6.88 (1
H, d, J 8.5), 6.32 (1 H, d, J 2.7), 6.05 (1 H, dd, J 8.5, 2.7), 5.45 (2 H, s), 3.68
(3 H, s)., disulfide (9) than 4-methoxy-2-aminothiophenol (10) . As a result,
we decided to prepare product (9) by the same reaction conditions
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2,4-Dihydroxy-5-(2-amino-4-methoxy-phenylthio)pyrimidine (11).
1-(4-methoxy-2-aminothiophenol)-4-methoxy-2-aminothiophenol(9)
(1.02 mmol, 0.316 g) was dissolved in diglyme(4 mL), and was reduced to
2-amino-4-methoxythiophenol (10) by heating with dithiothreitol, DTT, (1.02
mmol, 0.158 g) under nitrogen at 80°C. After 30 min 5-Bromouracil (2.1
mmol, 0.416 g) and Na2CO3 (2.04 mmol, 0.216 g) were added and the
mixture was heated at 120°C 2 h. The solvent was removed by evaporation
using rotary evaporator. Purification via flash column chromatography on
silica gel (5% methanol in dichloromethane) afforded the desired product
(11) in 0.18 g, 33% yield.

1

H NMR (500 MHz, DMSO-d6, 294 K): δ 11.33

(2 H, s), 7.27 (1 H, d, J 8.5), 6.27 (1 H, d, J 2.7), 6.12 (1 H, d, J 2.7), 6.11 (1
H, d, J 2.7), 5.60 (2 H, s), 3.66 (3 H, s).
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8-methoxy-1,3-diaza-2- oxophenothiazine nucleoside (tC8OMe base)
(12).
2,4-Dihydroxy-5-(2-amino-4-methoxy-phenylthio)pyrimidine (11) (0.49
mmol, 0.13 g) was dissolved in butanol (1 mL). While the mixture was
stirring, HCl (0.5 mL, 37%) was added dropwise. The reaction mixture was
heated at 116° C. After 22 h the mixture was cooled to room temperature
and the solvent was removed by evaporation via rotary evaporation.
Purification via flash column chromatography on silica gel (8% methanol in
dichloromethane) afforded the desired product (12) in 0.036 g, 30% yield.
1

H-NMR (500 MHz, DMSO-d6, 294 K): δ 11.04 (1 H, s), 10.16 (1 H, s), 7.42

(1 H, s), 6.96 (1 H, d, J 8.5), 6.58 (1 H, s), 6.53 (1 H, dd, J 8.6, 2.7), 3.68
(3H, s). (ESI-TOF) m/z: calcd. for C11H9N3O2S [M+H] 248.29 found 248.0.
ESI-TOF) m/z: calcd. for C11H9N3O2S [M+Na] 270.26 found 270.0.
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2´-deoxy-3´,5´-bis-O-p-toluoyl-8-methoxy-phenothiazine (13).
8-methoxy-1,3-diaza-2- oxophenothiazine

nucleoside (tC8OMe base)

(12) (0.877 mmol, 0.2 g) was stirred in anhydrous acetonirile 99% (2.12
mL)

at room temperature under nitrogen for 10min. Bis(trimethylsilyl)

acetamide (0.3 mL) was added to the solution. After 40 min, the reaction
was cooled to 0° C. 3´,5´-bis(toluoyl)-2-deoxyribosyl chloride (1.13 mmol,
0.44 g) was added, and followed by dropwise addtion of SnCl4 (6 µl ). The
progress of the reaction was monitored by TLC.

The reaction was

completed after 4 h. The mixture was dissolved in ethyl acetate (3 mL), and
the resulting solution was washed with saturated NaHCO3 (3x20 mL) and
brine (1x20 mL). The organic layer was dried over anhydrous Na2SO4, and
concentrated using a rotary evaporator. Purification via flash column
chromatography on silica gel (100:0 →60:40, CH2Cl2: MeOH) afforded the
desired product (13) as a mixture of β and α anomers ~ 1:1, 0.21 g, 40%
yield.

1

H NMR (500 MHz, Chloroform-d, 294 K): δ 7.94 (2 H, d, J 1.5),

7.93 (2 H, d, J 1.4), 7.90 (1 H, d, J 1.6), 7.88 (1 H, d, J 1.7), 7.73 (1 H, d, J
1.8), 7.72 (1 H, d, J 1.8), 7.46 (1 H, s), 7.44 (1 H, s), 7.21 (1 H, s), 7.20 (1 H,
s), 7.02 (1 H, s), 7.00 (1 H, s), 6.88 (1 H, d, J 8.6), 6.81 (1 H, d, J 8.5), 6.71
(1 H, d, J 2.6), 6.59 (2 H, t, J 2.7), 6.57 (1 H, d, J 2.5), 6.55 (1 H, dd, J 8.5,
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2.5), 6.33 (1 H, dd, J 8.0, 5.5), 6.28 (1 H, d, J 6.5), 5.62 (1 H, d, J 5.8), 5.59
(1 H, d, J 6.4), 4.89 (1 H, t, J 4.3), 4.78 (1 H, dd, J 12.3, 2.9), 4.66 (1 H, dd,
J 12.2, 3.3), 4.60 (1 H, q, J 2.8), 4.54 – 4.51 (2 H, m), 3.79 (3 H, s).

3-(2-Deoxy-b-D-ribofuranosyl)-8-methoxy-1,3-diaza-oxo-phenothiazine
(14) & (15).

2´-deoxy-3´,5´-bis-O-p-toluoyl-8-methoxy-phenothiazine
mmol, 0.209 g)

(13)

was dissolved in absolute methanol (5 mL)

(0.35
at room

temperature. NaOMe (30% wt. 5.4 M, 99% in methanol) (0.1 mL) was
added dropwise to the solution. After 30 min the reaction was complete,
and drops of acetic acid were added to quench. The solvent was removed
by evaporation using a rotary evaporator. Purification via flash column
chromatography on silica gel (CH2Cl2: MeOH, 100:0 → 55:45) afforded free
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isolated nucleoside anomers (14) & (15) β and α respectively that were
identified depending on the elution profile from automated chromatography
using an Isco gradient (CombiFlash® Rf ) and confirmed via 1H NMR 500.
The combined yield is 0.042 g, 34 %.
β anomer
1

H NMR (500 MHz, Methanol-d4, 294 K): δ 7.93 (1 H, s), 6.91 (1 H, d, J

8.6), 6.58 (1 H, d, J 2.6), 6.56 (1 H, d, J 2.6), 6.51 (1 H, d, J 2.5), 6.19 (1 H,
t, J 6.4), 4.93 (1 H, s), 4.85 (1 H, s), 4.61 (1 H, s), 4.37 – 4.35 (1 H, m), 3.93
(1 H, p, J 3.5), 3.82 (1 H, dd, J 12.1, 3.1), 3.75 (3 H, s), 2.36 (2 H, ddd, J
13.6, 6.1, 4.0), 2.17 – 2.15 (1 H, m), 2.15 – 2.11 (1 H, m).
α anomer
1

H NMR (500 MHz, Methanol-d4, 294 K): δ 7.69 (1 H, s), 6.93 – 6.89 (1 H,

m), 6.57 (1 H, dd, J 8.6, 2.6), 6.51 (1 H, d, J 2.6), 6.09 (1 H, dd, J 7.2, 2.1),
4.81 (1 H, s), 4.61 (3 H, s), 4.34 (2 H, dd, J 4.7, 3.4), 3.80 (1 H, s), 3.75 (3
H, s), 2.71 – 2.62 (1 H, m), 2.09 (1 H, s), 2.06 (1 H, s).
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1-(5-methoxy-2-aminothiophenol)-5-methoxy-2-amino-thiophenol (17).
Hydrazine monohydrate (10 mL) was added to 6-methoxy-2-methylbenzothiazole (16) (5.58 mmol, 1g). The mixture was heated at 100° C for
22 h. Hydrogen peroxide was added dropwise and the mixture was left to
evaporate in the hood two days. The crude product was dissolved in
methanol and precipitated by the addition of water. The afforded yellow
precipitate was collected via filtration and washed with water affording the
desired product (17) in 0.504 g, 60% yield. 1H NMR (500 MHz, DMSO-d6,
294 K): δ 6.77 (1 H, dd, J 8.7, 2.9), 6.70 (1 H, d, J 8.8), 6.59 (1 H, d, J 2.9),
5.04 (2 H, s), 3.52 (3 H, s).
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2,4-Dihydroxy-5-(2-amino-5-methoxy-phenylthio)pyrimidine (19).
1-(5-methoxy-2-aminothiophenol)-5-methoxy-2-aminothiophenol

(17)

(1.67 mmol, 0.515g) was dissolved in diglyme (10 mL). Triethylphosphine in
1 M tetrahydrofuran (1.669 mL) and water (0.03 mL) were added to reduce
the disulfide bond and afforded 2-amino-5-methoxythiophenol (18) at room
temperature. After 30 min, 5-Bromouracil (3.34 mmol, 0.637g) and Na2CO3
(3.34 mmol, 0.353 g) were added. The mixture was heated at 120°C for 1h.
The solvent was removed by evaporation using a rotary evaporator.
Purification via flash column chromatography on silica gel (CH2Cl2: MeOH,
100:0 → 20:80) afforded the desired product (19) in 0.307 g, 35% yield.1HNMR (500 MHz, DMSO-d6, 294 K): δ 11.28 (2 H, d, J 74.4), 7.59 (1 H, s),
6.89 (1 H, d, J 2.9), 6.72 (1 H, dd, J 8.8, 2.9), 6.65 (1 H, d, J 8.7), 5.05 (2 H,
s), 3.62(3 H,s)
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7-methoxy-1,3-diaza-2- oxophenothiazine

nucleoside (tC7OMe base)

(20).
2,4-Dihydroxy-5-(2-amino-5-methoxy-phenylthio)pyrimidine (19) (0.58
mmol, 0.154 g) was stirred in butanol (10 mL) at 100°C for 10 min. The
mixture was cooled to room temperature, followed by dropwise addition of
HCl (1 mL, 37%). The reaction mixture was heated overnight at 116°C, an
orange precipitate was generated which became yellow after washing with
water yielding 0.087g, 61%. tC7OMe base (20). No further purification was
necessary for the tC7OMe base (20).

1

H-NMR (500 MHz, DMSO-d6, 294 K):

δ 10.90 (1 H, s), 10.11 (1 H, s), 7.38 (1 H, s), 6.84 (1 H, d, J 8.6), 6.65 (2 H,
d, J 8.7), 3.67 (3 H, s). (ESI-TOF) m/z: calcd. for C11H9N3O2S [+H+] 248.29

92

found 248.1. (ESI-TOF) m/z: calcd. for C11H9N3O2S [+Li+] 254.21 found
254.1. (ESI-TOF) m/z: calcd. for C11H9N3O2S [Na+] 270.26 found 270.0.

2´-deoxy-3´,5´-bis-O-p-toluoyl-7-methoxy-phenothiazine(21).
7-methoxy-1,3-diaza-2- oxophenothiazine

nucleoside (tC7OMe base)

(20) (0.39 mmol, 0.096 g) was dissolved in anhydrous acetonitrile 99% (1
mL)

at

room

temperature

under

nitrogen

for

10

min.

Bis(trimethylsilyl)acetamide (0.133 mL) was added to the solution. After 40
min stirring at room temperature, 3´,5´-bis(toluoyl)-2-deoxyribosyl chloride
(0.504 mmol, 0.194 g) was added at 0º C followed by dropwise addition of
SnCl4 (8.34 µl). The progress of the reaction was monitored by TLC. The
reaction was completed after 4 h, the mixture was dissolved in ethyl
acetate, and the resulting solution was washed with saturated NaHCO3
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(3x20 mL) and brine (1x20 mL). The organic layer was dried over
anhydrous Na2SO4, and concentrated by evaporation of the solvent by a
rotary evaporator. Purification via flash column chromatography on silica gel
(100:0 → 60:40, CH2Cl2: MeOH) afforded the desired product (21) in
mixture of α and β anomers 0.1093 g, 47% yield. 1H-NMR (500 MHz,
Chloroform-d, 294 K): δ 8.03 (2 H, d, J 7.9), 7.96 – 7.92 (4 H, m), 7.91 –
7.88 (2 H, m), 7.75 – 7.73 (1 H, m), 7.21 (2 H, d, J 8.1), 7.02 (1 H, d, J 7.9),
6.87 (0 H, d, J 8.7), 6.79 (1 H, d, J 8.7), 6.67 (1 H, dd, J 8.7, 2.7), 6.61 (1 H,
dd, J 8.7, 2.7), 6.53 (0 H, d, J 2.7), 6.46 (1 H, d, J 2.7), 6.35 (1 H, dd, J 8.2,
5.5), 6.29 (1 H, d, J 6.4), 5.63 – 5.56 (2 H, m), 4.88 (1 H, t, J 4.2), 4.78 (1 H,
dd, J 12.3, 3.0), 4.66 (1 H, dd, J 12.2, 3.3), 4.58 (1 H, q, J 2.8), 4.55 – 4.51
(1 H, m), 3.75 (3 H, s), 3.35 (1 H, s).
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3-(2-Deoxy-b-D-ribofuranosyl)-7-methoxy-1,3-diaza-2-oxophenothiazine (22) & (23)
NaOMe (30% wt. 5.4 M, 99% in methanol) (0.2 mL) was added
dropwise to 2´-deoxy-3´,5´-bis-O-p-toluoyl-7-methoxy-phenothiazine (21)
(0.0233 mmol, 0.014 g) dissolved in methanol (3 mL) at room temperature.
After 30 min the reaction was complete, and drops of acetic acid were
added to quench the reaction then the solvent was removed by evaporation
with a rotary evaporator. Purification via flash column chromatography on
silica gel (CH2Cl3: MeOH, 100:0 → 60:40) afforded isolated free nucleoside
anomers β and α that were identified depending on the elution profile from
automated chromatography using an Isco gradient (CombiFlash® Rf ) in
yield (~ 9.46 % β & 4.72 % α and mixture α >> β

yield 43.7%)

and

confirmed via 1H NMR 500. In combined is yield 0.0057 g, 67 %. (ESI-TOF)
m/z: calcd. for C32H29N3O7S [+H+] 600.66 found 600.2. (ESI-TOF) m/z:
calcd. for C32H29N3O7S [+Li+] 606.59 found 606.2. (ESI-TOF) m/z: calcd. for
C32H29N3O7 [+Na+] 622.64 found 622.2.
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Scheme 3.7.15: The synthesis of 2,4-Dihydroxy-5-(2-amino-5-nitro-phenylthio)pyrimidine

2,4-Dihydroxy-5-(2-amino-5-nitro-phenylthio)pyrimidine (tCnitro) (27).
6-Nitrobenzothiazole (24) (13.87 mmol, 2.5 g) was dissolved in ethanol
(28 mL). After 5 min, hydrazine monohydrate (28 mL) was added to the
solution. The reaction mixture was heated at 100 °C for 18h. The 1-(5-nitro2-aminothiophenol)-5-nitro-2-aminothiophenol,

nitro-disulfide,

(25)

was

generated and collected via filtration then washed with water to afford the
yellow product in around ~100% yield. 1H NMR (500 MHz, DMSO-d6, 294
K): δ 7.99 (1 H, dd, J 9.2, 2.7), 7.49 (1 H, d, J 2.7), 7.23 (2 H, s), 6.85 (1 H,
d, J 9.2). 1-(5-nitro-2-aminothiophenol)-5-nitro-2-aminothiophenol, nitrodisulfide, (25) (0.65 mmol, 0.22 g) was dissolved in diglyme (8 mL).
Dithiothreitol (1.08 mmol, 0.167g) and water (0.03 mL) were added to
reduce the disulfide bond, and the reaction mixture was heated at 80°C to
afford 5-nitro-2-aminothiophenol (26). 5-Bromouracil (1.3 mmol, 0.248 g)
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and Na2CO3 (1.3 mmol, 0.137 g) were added. The mixture was heated at
120°C for 17 h. The mixture was left to evaporate in the hood two days.
Purification via flash column chromatography on silica gel (5% methanol in
dichloromethane) afforded the desired product (27) in 0.156 g, 71 % yield.
1

H-NMR (500 MHz, DMSO-d6, 294 K): δ 8.24 (2 H, d, J 2.7), 8.06 (2 H, s),

6.74 (1 H, s), 6.73 (1 H, s), 5.76 (2 H, s). (ESI-TOF) m/z: calcd. for
C12H10N4O4S2 [+H+] 281.27 found 281.0. (ESI-TOF) m/z: calcd. for
C12H10N4O4S2 [+K+] 319.36 found 319.0. (ESI-TOF) m/z: calcd. for
C12H10N4O4S2 [+Na+] 303.25 found 303.0.

7-nitro-1,3-diaza-2- oxophenothiazine nucleobase (tCnitro base) (28).
2,4-Dihydroxy-5-(2-amino-5-methoxy-phenylthio)pyrimidine (27) (0.082
mmol, 0.23 g) was stirred in

butanol (1.15 mL) followed by dropwise
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addition of HCl (0.4 mL, 37%). The reaction mixture was heated 3 days at
170°C.

The crude product was left to dry in the hood. The NMR

measurement shows the target product (28) was generated.

1

H-NMR (500

MHz, DMSO-d6, 294 K): δ 7.40 (1 H, s), 7.39 (2 H, d, J 1.8), 7.37 (1 H, s),
5.45 (1 H, d, J 1.6), 5.44 (1 H, d, J 1.8). (ESI-TOF) m/z: calcd. for
C10H6N4O3S [+H+] 263.25 found 263.0. (ESI-TOF) m/z: calcd. for
C10H6N4O3S [M+•] 262.24 found 262.0. (ESI-TOF) m/z: calcd. for
C10H6N4O3S [+Li+] 269.19 found 269.0. (ESI-TOF) m/z: calcd. for
C10H6N4O3S Na [+Na+] 285.23 found 285.0.

3.8 Conclusion
We have successfully synthesized two new tC fluorescent nucleosides
with methoxy substitutions, tC8OMe (Figure 3.2.2) , tC7OMe(Figure 3.2.3) , in
addition to preparing tC (Figure 3.2.1) which has been reported previously
by Matteucci and co-workers 2, and introduced a new synthetic route to
tCnitro that previously had been prepared in low yield by Börjesson et. al.
2009.4
The fluorescence study on the tC derivatives suggested that the
emission spectra in ethanol of tC8OMe, with a maximum at ~ 518 nm, has the
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greatest red shift, approximately 35 nm as compared to tC with a maximum
at ~ 483 nm. The emission spectra of tC7OMe, with a maximum at ~ 498 nm
is slightly red-shifted, approximately 15 nm as compared to tC. Likewise, the
emission spectrum in water of tC8OMe, with a maximum at ~ 537 nm, has the
greatest red shift, approximately 35 nm as compared to tC with a maximum
at ~ 502 nm, while the emission spectrum of tC7OMe, with a maximum at ~
517 nm was slightly red-shifted, approximately 15 nm as compared to tC.
The absorption spectrum of tC8OMe is also red-shifted compared to the
absorption spectrum of tC. The absorbance maximum of tC8OMe is generally
around 377 nm in ethanol, and 381 nm in water, which means that it is redshifted approximately 4 nm compared to the absorbance maximum of tC
that is generally around 373 nm in ethanol, and 377 nm in water. Whereas
the absorbance maximum of tC7OMe is generally around 374 in ethanol, and
376 nm in water, which means that it is red-shifted in ethanol, but blue
shifted in water approximately 1 nm compared to tC.
The quantum yields of both tC8OMe and tC7OMe, that were calculated via a
plot of integrated emission versus absorption (Figure 3.7.3), were relatively
high (0.38, and 0.8 respectively) compared to the tC quantum yield of 0.21.
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These results demonstrated that the tC7OMe, which has the methoxy donor
group para to the amino group, has the highest quantum yield and
brightness.
To sum up, our results suggest that the different substitution positions
create important distinctions between the nucleosides derivatives of tC. The
unsubstituted tC nucleoside was easy to synthesize. In contrast, the
synthetic strategy of the tC7OMe nucleoside that has the methoxy electron
donor substituent group located at carbon 7 and para to the amino group is
synthetically less challenging and higher yielding than the synthesis of
tC8OMe which has the methoxy group substituent meta to the amine group.
Moreover, the donor substituent and the position of the substituent have
affected the photophysical properties of the fluorescent nucleoside
derivatives of tC. The fluorescence studies demonstrated that fluorescence
emission and absorption wavelengths for tC7OMe and tC8OMe were red shifted
compared to the unmodified tC. That means, the methoxy donor group
which allows for extended conjugation of unshared pairs of electrons leads
to an increase in the freedom of the
fluorescence.

-electrons and this is likely to raise the

Also, our fluorescence study established that there are

effects of the different positions of the substituent donor group. The
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fluorescence emission wavelength of tC8OMe, where methoxy is meta to the
amino group, is red shifted longer than the fluorescence emission
wavelength of tC7OMe, where methoxy is para to the amino group.
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Appendix A
NMR Spectra
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